These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 20626412)

  • 1. Impact of UK National Guidelines based on FRAX®--comparison with current clinical practice.
    Crabtree NJ; Bebbington NA; Chapman DM; Wahid YS; Ayuk J; Boivin CM; Cooper MS; Gittoes NJ;
    Clin Endocrinol (Oxf); 2010 Oct; 73(4):452-6. PubMed ID: 20626412
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Access to fracture risk assessment by FRAX and linked National Osteoporosis Guideline Group (NOGG) guidance in the UK-an analysis of anonymous website activity.
    McCloskey EV; Johansson H; Harvey NC; Compston J; Kanis JA
    Osteoporos Int; 2017 Jan; 28(1):71-76. PubMed ID: 27438128
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Usefulness of FRAX tool for the management of osteoporosis in the Spanish female population].
    Azagra Ledesma R; Prieto-Alhambra D; Encabo Duró G; Casado Burgos E; Aguyé Batista A; Díez-Pérez A;
    Med Clin (Barc); 2011 May; 136(14):613-9. PubMed ID: 21349558
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fragility fracture risk in cirrhosis: a comparison of the fracture risk assessment tool, British Society of Gastroenterology and National Institute for Health and Clinical Excellence guidelines.
    Ayres LRO; Clarke S; Digby-Bell J; Dhanda AD; Dharmasiri S; Caddick K; Collins PL
    Frontline Gastroenterol; 2012 Oct; 3(4):220-227. PubMed ID: 28839671
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predicting fracture risk in osteoporosis: the use of fracture prediction tools in an osteoporosis clinic population.
    Aw D; Thain J; Ali A; Aung T; Chua WM; Sahota O; Weerasuriya N; Marshall L; Kearney F; Masud T
    Postgrad Med J; 2016 May; 92(1087):267-70. PubMed ID: 26792635
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Osteoporosis Management in a Real Clinical Setting: Heterogeneity in Intervention Approach and Discrepancy in Treatment Rates when Compared with the NOGG and NOF Guidelines.
    Kyriakos G; Vidal-Casariesgo A; Quiles-Sánchez LV; Urosa-Maggi JA; Calleja-Fernández A; Hernández-Moreno A; Ballesteros-Pomar MD; Cano-Rodriguez I
    Exp Clin Endocrinol Diabetes; 2016 Sep; 124(8):466-473. PubMed ID: 27219881
    [No Abstract]   [Full Text] [Related]  

  • 7. Application of the World Health Organization Fracture Risk Assessment Tool to predict need for dual-energy X-ray absorptiometry scanning in postmenopausal women.
    Chao AS; Chen FP; Lin YC; Huang TS; Fan CM; Yu YW
    Taiwan J Obstet Gynecol; 2015 Dec; 54(6):722-5. PubMed ID: 26700992
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of the NOGG and NOF Guidelines on the Indication of Bone Mineral Density in Routine Clinical Practice.
    Kyriakos G; Vidal-Casariego A; Fernández-Martínez MN; Blanco-Suárez MD; Ballesteros-Pomar MD; Cano-Rodríguez I
    J Clin Densitom; 2015; 18(4):533-8. PubMed ID: 26343823
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of clinical risk factors for osteoporosis and applicability of the FRAX tool in Joinville City, Southern Brazil.
    Silva DMW; Borba VZC; Kanis JA
    Arch Osteoporos; 2017 Dec; 12(1):111. PubMed ID: 29224172
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A systematic review of intervention thresholds based on FRAX : A report prepared for the National Osteoporosis Guideline Group and the International Osteoporosis Foundation.
    Kanis JA; Harvey NC; Cooper C; Johansson H; Odén A; McCloskey EV;
    Arch Osteoporos; 2016 Dec; 11(1):25. PubMed ID: 27465509
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The relationship between the OSTEODENT index and hip fracture risk assessment using FRAX.
    Horner K; Allen P; Graham J; Jacobs R; Boonen S; Pavitt S; Nackaerts O; Marjanovic E; Adams JE; Karayianni K; Lindh C; van der Stelt P; Devlin H
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 Aug; 110(2):243-9. PubMed ID: 20659701
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical decision support system for the management of osteoporosis compared to NOGG guidelines and an osteology specialist: a validation pilot study.
    Gudmundsson HT; Hansen KE; Halldorsson BV; Ludviksson BR; Gudbjornsson B
    BMC Med Inform Decis Mak; 2019 Feb; 19(1):27. PubMed ID: 30709348
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Fracture Risk Assessment Tool (FRAX®): applications in clinical practice.
    Watts NB
    J Womens Health (Larchmt); 2011 Apr; 20(4):525-31. PubMed ID: 21438699
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of fracture risk assessment tool score to bone mineral density for estimating fracture risk in patients with advanced prostate cancer on androgen deprivation therapy.
    James H; Aleksic I; Bienz MN; Pieczonka C; Iannotta P; Albala D; Mariados N; Mouraviev V; Saad F
    Urology; 2014 Jul; 84(1):164-8. PubMed ID: 24976229
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Osteoporosis - whom to treat? The importance of FRAX® in Switzerland].
    Lippuner K
    Ther Umsch; 2012 Mar; 69(3):207-13. PubMed ID: 22403115
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevention of Glucocorticoid-Induced Osteoporosis: Clinical audit to evaluate the implementation of National Osteoporosis Guideline Group 2017 guidelines in a primary care setting.
    Carter M
    J Clin Densitom; 2019; 22(1):25-30. PubMed ID: 29729949
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparative study between the implementation of the FRIDEX calibration and the NOGG guideline in the management of osteoporosis in routine clinical practice.
    Kyriakos G; Vidal-Casariego A; Quiles-Sánchez LV; Calleja-Fernández A; Ávila-Turcios D; Urosa-Maggi JA; Ballesteros-Pomar MD; Cano-Rodríguez I
    Reumatol Clin; 2017; 13(5):258-263. PubMed ID: 27373582
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fracture assessment tool risk scores in bone density reports do not change physician prescribing behavior for osteoporosis.
    Izuora KE; Alazraki N; Byrd-Sellers J; Tangpricha V; Nanes MS
    Am J Med Sci; 2011 Jul; 342(1):5-8. PubMed ID: 21412137
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of a FRAX-based intervention threshold in Turkey: the FRAX-TURK study.
    Tuzun S; Eskiyurt N; Akarirmak U; Saridogan M; Johansson H; McCloskey E; Kanis JA;
    Arch Osteoporos; 2012; 7():229-35. PubMed ID: 23060308
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An assessment of intervention thresholds for very high fracture risk applied to the NOGG guidelines : A report for the National Osteoporosis Guideline Group (NOGG).
    Kanis JA; Johansson H; Harvey NC; Lorentzon M; Liu E; Vandenput L; McCloskey EV
    Osteoporos Int; 2021 Oct; 32(10):1951-1960. PubMed ID: 33813622
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.